1BLOOMGARDEN Z T.Insulin resistance:current concepts[J].Clin Ther,1998,20(2):215-216. 被引量：1
2MIYAZAKI Y,MAHANKALI A,MATSUDA M,et al.Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone[J].Diabetes Care,2001,24(4):710-719. 被引量：1
3ROSENBLATT S,MISKIN B,GLAZER N B,et al.The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus[J].Coron Artery Dis,2001,12(5):413-423. 被引量：1
4CHILCOTT J,TAPPENDEN P,JONES M L,et al.A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus[J].Clin Ther,2001,29(11):1792-1823. 被引量：1
5SIVITZ W I.Lipotoxicity and glucotoxicity in type 2 diabetes.Effects on development and progression[J].Postgrad Med,2001,109(4):55-59. 被引量：1
